REGEN BIOPHARMA, INC. (RGBPP) Operating income 2017–2025
REGEN BIOPHARMA, INC. (RGBPP) annual operating income history from SEC filings — each fiscal year as reported.
-$338,540FY2025 · since FY2017: -$2.5M → -$338,540
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$338,540 | +18.9% |
| FY2024 | -$417,221 | +39.3% |
| FY2023 | -$686,950 | -102.3% |
| FY2022 | -$339,605 | -69.2% |
| FY2021 | -$200,771 | +4.1% |
| FY2020 | -$209,317 | +72.3% |
| FY2019 | -$756,785 | +46.9% |
| FY2018 | -$1.4M | +43.2% |
| FY2017 | -$2.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RGBPP financial trends
RGBPP RevenueRGBPP Net incomeRGBPP Net marginRGBPP Gross profitRGBPP Gross marginRGBPP Operating marginRGBPP Operating cash flowRGBPP Free cash flowRGBPP Capital expendituresRGBPP Return on equityRGBPP Stock buybacksRGBPP Dividends paidRGBPP Total assetsRGBPP Total liabilitiesRGBPP Shareholders’ equityRGBPP overview →